Presentation at CHEST Annual Meeting 2022: Comparison Between Pulmonary Arterial Hypertension (PAH) Risk Assessment Methods, Including Pulmonary Hypertension Outcome Risks Assessment (PHORA) 

Fauvel, C., Liu, Z., Lin, S., Correa-Jaque, P., Webb, A., Vanderpool, R., Kanwar, M., Kraisangka, J., Mathur, P., Perer, A., Everett, A., & Benza, R. L.  “Comparison Between Pulmonary Arterial Hypertension (PAH) Risk Assessment Methods, Including Pulmonary Hypertension Outcome Risks Assessment (PHORA)” PURPOSE: Risk assessment is critical to predict survival and then guide therapeutic management for pulmonary […]